Aequus Pharmaceuticals Inc.
AQSZFOTCHealthcare● Active
$0.00
+$0.00(+136.36%)
Market Cap$344850
P/E Ratio—
52W High$0.008
52W Low$0.0001
Aequus Pharmaceuticals Inc. (AQSZF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AQSZF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2025Report Date: Dec 1, 2025EPS Actual
$0.00
Revenue
$0.00B
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Dec 1, 2025
After Market Close
AQSZF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.20
Rev. $3.00B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.20
Rev. Est.$3.00B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 8, 2026 | — | — | — | — | — | — |
| — Q4 FY2025 | Dec 1, 2025 | — | $0.00 | — | $0.00B | — | — |
| — Q3 FY2025 | Aug 27, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2025 | May 21, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2025 | Apr 24, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2024 | Nov 8, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2024 | Aug 29, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2024 | May 9, 2024 | — | -$0.00 | — | $0.00B | — | — |
Q2 FY2026
Jun 8, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Dec 1, 2025
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Aug 27, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
May 21, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
Apr 24, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 8, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2024
Aug 29, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
May 9, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for AQSZF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2025 | Dec 1, 2025 | — | $0.00 | $0.00 | +0.00% |
| — Q3 FY2025 | Aug 27, 2025 | — | $0.00 | $0.00 | +0.00% |
| — Q2 FY2025 | May 21, 2025 | — | $0.00 | $0.00 | +0.00% |
| — Q2 FY2025 | Apr 24, 2025 | — | $0.00 | $0.00 | +33.33% |
| — Q4 FY2024 | Nov 8, 2024 | — | $0.01 | $0.01 | +0.00% |
| — Q3 FY2024 | Aug 29, 2024 | — | $0.02 | $0.02 | +0.00% |
| — Q2 FY2024 | May 9, 2024 | — | $0.01 | $0.01 | +56.42% |
| — Q2 FY2024 | Apr 29, 2024 | — | No price data | $0.01 | — |
Q4 FY2025+0.00%
Report Date
Dec 1, 2025
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q3 FY2025+0.00%
Report Date
Aug 27, 2025
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q2 FY2025+0.00%
Report Date
May 21, 2025
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q2 FY2025+33.33%
Report Date
Apr 24, 2025
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2024+0.00%
Report Date
Nov 8, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2024+0.00%
Report Date
Aug 29, 2024
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q2 FY2024+56.42%
Report Date
May 9, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2024—
Report Date
Apr 29, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$0.01
Beat Rate0 / 8 quarters
Largest Move+56.42% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AQSZF ends December
Aequus Pharmaceuticals Inc. (AQSZF) most recently reported earnings on December 1, 2025 for Q4 FY2025, posting EPS of $0.00 (in line with the analyst consensus of —). The next AQSZF earnings date is expected around September 1, 2026.
Each quarter, investors track AQSZF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AQSZF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AQSZF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AQSZF earnings · 4 questionsAequus Pharmaceuticals Inc.'s next earnings report is expected around September 1, 2026. AQSZF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AQSZF historically reports after market close (AMC).
AQSZF earnings datewhen is AQSZF earningsAQSZF next earnings datewhen does AQSZF report earningsAQSZF earnings calendar
▸ Source: FMP · Aequus Pharmaceuticals Inc. SEC filings · US GAAP · Aequus Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026